about
The Obesity-Breast Cancer Conundrum: An Analysis of the IssuesUnexploited Antineoplastic Effects of Commercially Available Anti-Diabetic DrugsEvidence for DNA damage as a biological link between diabetes and cancerSynthesis of aryl-heteroaryl ureas (AHUs) based on 4-aminoquinoline and their evaluation against the insulin-like growth factor receptor (IGF-1R).The key role of growth hormone-insulin-IGF-1 signaling in aging and cancerAtrial fibrillation as a marker of occult cancer.Diverse pathomechanisms leading to the breakdown of cellular estrogen surveillance and breast cancer development: new therapeutic strategies.Progesterone--promoter or inhibitor of breast cancer.Metformin for aging and cancer prevention.Diet and breast cancer: a systematic review.Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv miceIf started early in life, metformin treatment increases life span and postpones tumors in female SHR mice.Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials.Breast cancer and dietary patterns: a systematic review.Cancer in rodents: does it tell us about cancer in humans?Circulatory estrogen level protects against breast cancer in obese women.Dietary carbohydrates, fiber, and breast cancer risk in Chinese women.Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma.Glycemic index, glycemic load, and the risk of pancreatic cancer among postmenopausal women in the women's health initiative observational study and clinical trial.Metformin: do we finally have an anti-aging drug?The association between different kinds of fat intake and breast cancer risk in women.Physical activity, obesity and risk for esophageal adenocarcinoma.Insulin therapy in diabetes and cancer risk: current understanding and implications for future study: proceedings from a meeting of a European Insulin Safety Consensus Panel, convened and sponsored by Novo Nordisk, held Tuesday October 5, 2010 at ThImpact of diet on breast cancer risk: a review of experimental and observational studies.PEGylated insulin Lispro, (LY2605541)--a new basal insulin analogue.Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma.Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population.Sitagliptin 100 mg vs glimepiride 1-3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM).Biomarkers of aging, life span and spontaneous carcinogenesis in the wild type and HER-2 transgenic FVB/N female mice.Serum interleukin-6 associated with hepatocellular carcinoma risk: a nested case-control study.Induction of squamous cell carcinoma of forestomach in diabetic rats by single alloxan treatment.A Multi-country Ecological Study of Dietary Risk and Risk-reduction Factors for Prostate Cancer
P2860
Q26747486-FB95FEFC-9184-41B7-B3F1-7AD2C57CFF49Q26750845-F4254221-EB0A-403A-B4B3-070A80923167Q27001226-552F1D07-CA21-4A0A-B6E5-115A0FDC5667Q33636283-C8D2F62E-12EB-4B4D-A9FD-87BA40BAEFD9Q33893799-9447B586-20A1-49F1-8DDF-F9079074EBD4Q34066012-D5826EA8-993B-4D79-8CD1-DAF5E915B9ACQ34198265-62EAF450-D77B-4C67-922C-FE9DDC4ED05EQ34323606-089FCB58-10A9-4F4D-AB12-A6CBF58273CEQ34424886-D905FDB4-A179-4357-9149-1BC16BFA0BC4Q34437348-B13FF651-6DCF-46A5-B92E-EBAC9697CC36Q34554315-A10B4031-0B9F-4333-B203-04FB7C1FB174Q34852281-98C9F0F6-635C-4D40-9366-7C26DE1B559EQ35006620-1CCF0057-7700-4F08-8826-8F09C9525E33Q35065066-0C0A299B-0877-4A41-BB85-ABD45660E75EQ36272962-826E9D2F-0980-48C5-8109-CD6C4B3CEA97Q36795622-03ED6AF3-DCC3-4657-9F12-39125B81D59DQ37071667-66840445-1F87-4274-B556-200222F19603Q37155599-771D6804-C64D-43EA-BE2D-1A9644458273Q37237472-B1124C26-0DFB-44AA-804B-D015E8C70FDAQ37530252-30D3D2AE-5F8F-48FB-8D03-97EA7178E8E9Q37560211-D152B0E3-1301-45CE-B59B-8AC7771D21D9Q37605867-4A95BB03-A5FF-4AC2-B417-8C6E2F707F94Q37921639-0F98E9D7-76D6-4BB7-8194-E0C0394226B8Q38049353-C2089E9A-7A2F-4A63-BF4D-FC55282CFAA7Q38128590-06B8F5BD-0050-4B4B-AEA7-170AB3017D67Q45367471-11DA94F8-FD4C-4522-A567-B661C4901C36Q46654271-FB7E9CE6-7513-4784-93E6-6AD79D3DA9F6Q47144226-A0FF04BD-9BE4-4A04-87B9-1DF981693C27Q47996541-D28DA171-4F1A-4DB7-AAAD-F37D4756591AQ50892861-15B87123-1000-4D1D-8DD9-B003C3C8B054Q51790172-AF7B5E59-0854-49F6-90CE-CB5E9E582F2FQ57200700-7DA8BE28-D420-406B-B097-EFDCA1A2E6DF
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Insulin: a novel factor in carcinogenesis.
@ast
Insulin: a novel factor in carcinogenesis.
@en
Insulin: a novel factor in carcinogenesis.
@nl
type
label
Insulin: a novel factor in carcinogenesis.
@ast
Insulin: a novel factor in carcinogenesis.
@en
Insulin: a novel factor in carcinogenesis.
@nl
prefLabel
Insulin: a novel factor in carcinogenesis.
@ast
Insulin: a novel factor in carcinogenesis.
@en
Insulin: a novel factor in carcinogenesis.
@nl
P2093
P1476
Insulin: a novel factor in carcinogenesis.
@en
P2093
P304
P356
10.1097/00000441-200203000-00004
P407
P577
2002-03-01T00:00:00Z